Literature DB >> 8951920

Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling.

C S Cleeland1, Y Nakamura, T R Mendoza, K R Edwards, J Douglas, R C Serlin.   

Abstract

We investigated the question of how cultural and linguistic backgrounds affect relationships among ratings (reported by patients with metastatic cancer) of pain's interference with such functions as activity, mood, and sleep. Multidimensional scaling (MDS) was used to analyze ratings of pain interference from a sample consisting of four culturally and linguistically different groups from the US (n = 1106), France (n = 324), the Philippines (n = 267), and China (n = 146). Patients all completed the Brief Pain Inventory, a self-report measure of pain and its interference with function. For each of these samples, MDS solutions consistently revealed two interpretable dimensions. In all samples, one dimension represented affect and the other dimension represented activity. The dimensions were consistently interpretable across all four samples and across three levels of pain severity ('mild', 'moderate', and 'severe'). The dimensions were most prominent when pain was moderate, rather than mild (when little interference was produced) or severe (when all domains were highly interfered with). These dimensions may have utility in the study of the epidemiology of pain and of the effectiveness of pain treatment. They may also be useful in clinical assessment to describe different patterns of pain interference.

Entities:  

Mesh:

Year:  1996        PMID: 8951920     DOI: 10.1016/0304-3959(96)03131-4

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  72 in total

Review 1.  Developing effective cancer pain education programs.

Authors:  Michelle Y Martin; Maria Pisu; Elizabeth A Kvale; Shelley A Johns
Journal:  Curr Pain Headache Rep       Date:  2012-08

2.  Factors affecting symptom presentation in an early-phase clinical trials clinic patient population.

Authors:  Goldy C George; Tito R Mendoza; Eucharia C Iwuanyanwu; Meryna Manandhar; Solmaz F Afshar; Sarina A Piha-Paul; Apostolia Tsimberidou; Aung Naing; Charles S Cleeland; David S Hong
Journal:  Invest New Drugs       Date:  2019-11-25       Impact factor: 3.850

3.  Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society's Studies of Cancer Survivors.

Authors:  Qiuling Shi; Tenbroeck G Smith; Jared D Michonski; Kevin D Stein; Chiewkwei Kaw; Charles S Cleeland
Journal:  Cancer       Date:  2011-04-14       Impact factor: 6.860

4.  The use of a responder analysis to identify differences in patient outcomes following a self-care intervention to improve cancer pain management.

Authors:  Christine Miaskowski; Marylin Dodd; Claudia West; Steven M Paul; Karen Schumacher; Debu Tripathy; Peter Koo
Journal:  Pain       Date:  2007-01-25       Impact factor: 6.961

5.  Cancer-related symptom clusters, eosinophils, and survival in hepatobiliary cancer: an exploratory study.

Authors:  Jennifer L Steel; Kevin H Kim; Mary Amanda Dew; Mark L Unruh; Michael H Antoni; Marion C Olek; David A Geller; Brian I Carr; Lisa H Butterfield; T Clark Gamblin
Journal:  J Pain Symptom Manage       Date:  2010-05       Impact factor: 3.612

6.  The Brief Pain Inventory and its "pain at its worst in the last 24 hours" item: clinical trial endpoint considerations.

Authors:  Thomas M Atkinson; Tito R Mendoza; Laura Sit; Steven Passik; Howard I Scher; Charles Cleeland; Ethan Basch
Journal:  Pain Med       Date:  2010-01-15       Impact factor: 3.750

7.  Impact of cultural and linguistic factors on symptom reporting by patients with cancer.

Authors:  Xin Shelley Wang; Charles S Cleeland; Tito R Mendoza; Young Ho Yun; Ying Wang; Toru Okuyama; Valen E Johnson
Journal:  J Natl Cancer Inst       Date:  2010-03-26       Impact factor: 13.506

8.  Psychologic influence on experimental pain sensitivity and clinical pain intensity for patients with shoulder pain.

Authors:  Steven Z George; Adam T Hirsh
Journal:  J Pain       Date:  2008-12-13       Impact factor: 5.820

9.  Development of a crosswalk for pain interference measured by the BPI and PROMIS pain interference short form.

Authors:  Robert L Askew; Jiseon Kim; Hyewon Chung; Karon F Cook; Kurt L Johnson; Dagmar Amtmann
Journal:  Qual Life Res       Date:  2013-03-29       Impact factor: 4.147

10.  Primary Sjögren's Syndrome: health experiences and predictors of health quality among patients in the United States.

Authors:  Barbara Segal; Simon J Bowman; Philip C Fox; Frederick B Vivino; Nandita Murukutla; Jeff Brodscholl; Sarika Ogale; Lachy McLean
Journal:  Health Qual Life Outcomes       Date:  2009-05-27       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.